ArticleJournal of public health in Africa2025
Enhancing health security in Africa: Collaboration between public health institutes and academia.
Article in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic exposed significant challenges in Africa, including weak health systems, misinformation, limited vaccine access, and a lack of local data. Effective country-level leadership, coordination, and communication were crucial in addressing these multifaceted challenges. Aim: The Program for Research on Vaccine Effectiveness (PROVE) was established to address these challenges by fostering international partnerships and advancing scientific knowledge generation toward implementing the Africa Centers for Disease Control and Prevention's New Public Health Order. Setting: The PROVE program is a collaborative initiative under the Saving Lives and Livelihoods initiative of Africa CDC and the Mastercard Foundation. It brings together a diverse network of researchers and policymakers from National Public Health Institutions and academia across Africa. Methods: The programme employs a variety of qualitative and quantitative research methods, including surveys, interviews, focus groups, and analysis of existing data, along with capacity-building efforts. Results: The PROVE program has achieved several significant results, including: developing evidence-based policy recommendations to strengthen DHIS2 and other data systems; strengthening the capacity of National Public Health Institutions; fostering collaboration among researchers, policymakers, and public health professionals; and promoting the use of local data for evidence-informed decision-making. Conclusion: The PROVE programme's collaborative approach is a valuable initiative with the potential to improve evidence generation and utilisation in Africa. By encouraging collaboration, knowledge generation and building capacity of local scientists in implementation science, the initiative helps address the challenges posed by the COVID-19 pandemic and builds resilience against future public health emergencies. Contribution: This paper describes PROVE's innovative approaches to generating new knowledge, developing practical approaches, and building capacity among African researchers in collaboration with policymakers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.